D
Inhibikase Therapeutics, Inc. IKT
$1.66 -$0.01-0.60% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2026 12/31/2025 09/30/2025 06/30/2025 03/31/2025
Total Cash And Short-Term Investments -4.70% 131.19% -11.80% -5.92% -4.47%
Total Receivables -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses 298.18% -46.38% -9.70% -27.50% 9.74%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -47.43% 65.49% 31.71% 508.00% -4.67%
Total Current Assets -4.40% 129.33% -11.55% -5.70% -4.35%

Total Current Assets -4.40% 129.33% -11.55% -5.70% -4.35%
Net Property, Plant & Equipment -- -- -100.00% -49.74% -21.48%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 5.54% 3.52% -- -- --
Total Assets -4.34% 127.66% -10.42% -5.76% -4.38%

Total Accounts Payable 37.06% 86.64% -77.05% 59.78% 79.44%
Total Accrued Expenses 1.06% 11.62% 16.23% -10.45% 31.09%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -49.33% -32.31%
Total Finance Division Other Current Liabilities -- 26.54% -16.93% -10.96% --
Total Other Current Liabilities -- 26.54% -16.93% -10.96% --
Total Current Liabilities -31.19% 23.96% -23.90% 2.91% 129.02%

Total Current Liabilities -31.19% 23.96% -23.90% 2.91% 129.02%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities -31.19% 23.96% -23.90% 2.91% 129.02%

Common Stock & APIC 3.53% 55.57% 2.41% 2.19% 2.38%
Retained Earnings -11.48% -9.80% -10.11% -9.17% -14.49%
Treasury Stock & Other -220.64% 619.05% -44.83% -190.00% 97.31%
Total Common Equity -3.06% 137.18% -8.94% -6.62% -9.63%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity -3.06% 137.18% -8.94% -6.62% -9.63%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity -3.06% 137.18% -8.94% -6.62% -9.63%